MIRA INFORM REPORT

 

 

Report No. :

319491

Report Date :

24.04.2015

 

IDENTIFICATION DETAILS

 

Name :

ERIS LIFESCIENCES PRIVATE LIMITED (w.e.f. 09.02.2007)

 

 

Formerly Known As :

ERIS LIFESCIENCE PRIVATE LIMITED

 

 

Registered Office :

7th Floor, Commercial House, IV Besides Shell, Petrol Pump 100 Feet Road, Prahladnagar, Ahmedabad – 380015, Gujarat

Tel. No.:

91-79-30451111

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

25.01.2007

 

 

Com. Reg. No.:

04-049867

 

 

Capital Investment / Paid-up Capital :

Rs. 1.375 Million

 

 

CIN No.:

[Company Identification No.]

U24232GJ2007PTC049867

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

AHME00711E

 

 

PAN No.:

[Permanent Account No.]

AABCE7067M

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceuticals and Chemical Products and Medicaments.

 

 

No. of Employees :

150 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (52)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 5800000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

The subject is an established company having a satisfactory track record.

 

It is engaged in manufacturing, marketing and selling of branded generics across the country.

 

The company has reported increases in its sales turnover during FY 2014.

 

The company possesses debt-free balance, strong net worth and healthy liquidity.

 

Trade relation are fair. Business is active. Payments are reported to be usually correct.

 

The company can be considered for normal business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.


 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

INFORMATION PARTED BY (GENERAL DETAILS)

 

Name :

Ms. Kinnari

Designation :

Receptionist

Contact No.:

91-79-30451000

Date :

24.04.2015

 

 

LOCATIONS

 

Registered Office :

7th Floor, Commercial House, IV Besides Shell, Petrol Pump 100 Feet Road, Prahladnagar, Ahmedabad – 380015, Gujarat, India

Tel. No. :

91-79-30451111

Fax No. :

91-79-30451111

E-Mail :

ho.admin@erislifesciences.com

efficientbs@gmail.Com   

 

 

DIRECTORS

 

As on 30.09.2014

 

Name :

Mr. Amit Indubhushan Bakshi

Designation :

Managing director

Address :

B-44, Venus Apartments, Judges Bunglow Road, Bodakdev, Ahmedabad – 380001, Gujarat, India

Date of Birth/Age :

28.11.1974

Date of Appointment :

01.04.2011

PAN No.:

AGIPB4441Q

DIN No. :

01250925

 

 

Name :

Mr. Himanshu Jayantbhai Shah

Designation :

Director

Address :

A/74, Yash Tower, Near Shwetanjali Society, Opposite Hasubhai Park, Jodhpur Gam, Ahmedabad - 380018, Gujarat, India

Date of Birth/Age :

09.04.1976

Date of Appointment :

27.01.2007

DIN No. :

01301025

 

 

Name :

Mr. Rajendra Rambhai Patel

Designation :

Director

Address :

H-103, Akash - 3, 132ft Ring Road, Naranpura, Ahmedabad – 380013, Gujarat, India

Date of Birth/Age :

16.02.1977

Date of Appointment :

16.08.2012

DIN No. :

01229080

 

 

Name :

Mr. Inderjeet Singh Negi

Designation :

Director

Address :

42/D, Royal Orchid, Near Suyog Bunglow, Prahladnagar, Ahmedabad, 380015, Gujarat, India

Date of Birth/Age :

22.06.1971

Date of Appointment :

25.01.2007

DIN No. :

01255388

 

 

Name :

Mr. Kaushal Kamlesh Shah

Designation :

Director

Address :

2-B, Paradise Park, Opposite Shantinagar Bus Stop, Jain Agan Mandir, Ashram Road, Ahmedabad – 380014, Gujarat, India

Date of Birth/Age :

12.07.1979

Date of Appointment :

27.01.2007

DIN No. :

01229038

 

 

Name :

Mr. Bhikhabhai Chimanlal Shah

Designation :

Director

Address :

Paras '7', Vidhyanagar Society, No. III, Usmanpura, Ahmedabad – 380013, Gujarat, India

Date of Birth/Age :

24.05.1939

Date of Appointment :

25.01.2007

DIN No. :

01217618

 

 

Name :

Mr. Sanjiv Dwarkanath Kaul

Designation :

Director

Address :

22, Siris Road, DLF Qutab Enclave, Phase - 3, Gurgaon – 122002, Haryana, India

Date of Birth/Age :

25.07.1957

Date of Appointment :

29.08.2011

DIN No. :

01550413

 

 

KEY EXECUTIVES

 

Name :

Ms. Kinnari

Designation :

Receptionist

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2014

 

Names of Shareholders

No. of Shares

%age holding

Amit Indubhushan Bakshi

51521

37.47

Himanshu Jayantbhai Shah

6972

5.07

Rajendra Rambhai Patel

6971

5.07

Inderjeet Singh Negi

6971

5.07

Kaushal Kamlesh Shah

5500

4.00

Hetal Rasiklal Shah

5500

4.00

Rakesh Bhikhalal Shah

15867

11.54

Bhikhalal Chimanlal Shah

15854

11.53

Botticelli

22344

16.25

Total

137500

100.00

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2014

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

16.25

Directors or relatives of Directors

83.75

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceuticals and Chemical Products and Medicaments.

 

 

Products :

Pharmaceuticals and Chemical Products and Medicaments

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

L/C and Credit

 

 

Purchasing :

L/C and Credit

 

PRODUCTION STATUS NOT AVAILABLE

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

No. of Employees :

150 (Approximately)

 

 

Bankers :

Bank of Baroda, Navrangpura Branch, Navrangpura, Ahmedabad - 380009,

Gujarat, India

 

 

Facilities :

SECURED LOANS

31.03.2014

(Rs. In Millions)

31.03.2013

(Rs. In Millions)

LONG TERM BORROWINGS

 

 

Other loans and advances, others

0.000

0.374

Total

0.000

3.810

 

Auditors :

 

Name :

R R S and Associates

Chartered Accountants

Address :

211, Kamal Complex, Near Stadium Circle Road, C G Road, Ahmedabad, Gujarat, India

Income-tax PAN of auditor or auditor's firm :

AAFFR0472A

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Subsidiary:

Eris Therapeutics Private Limited

CIN No.: U24230GJ2009PTC057670

 

 

Other Related Party:

  • Sozin Flora Pharma
  • Eris Lifesciences Private Limited Employees Group Gratuity Trust Fund

 

 

CAPITAL STRUCTURE

 

As on 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000000

Equity Shares

Rs.10/- each

Rs.100.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

137500

Equity Shares

Rs.10/- each

Rs.1.375 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2014

31.03.2013

31.03.2012

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

1.375

1.375

1.375

(b) Reserves & Surplus

2034.671

1373.468

685.558

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

2036.046

1374.843

686.933

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.374

25.809

(b) Deferred tax liabilities (Net)

17.396

0.000

1.804

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

17.396

0.374

27.613

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

7.477

(b) Trade payables

214.482

159.488

115.591

(c) Other current liabilities

168.133

84.323

41.125

(d) Short-term provisions

57.261

31.494

22.880

Total Current Liabilities (4)

439.876

275.305

187.073

 

 

 

 

TOTAL

2493.318

1650.522

901.619

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

637.410

148.280

105.865

(ii) Intangible Assets

1.118

0.745

0.487

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

306.405

115.515

56.679

(c) Deferred tax assets (net)

0.000

0.557

0.000

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

944.933

265.097

163.031

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

641.056

465.000

134.516

(b) Inventories

454.854

519.682

230.628

(c) Trade receivables

219.470

163.102

141.839

(d) Cash and cash equivalents

59.019

35.164

88.634

(e) Short-term loans and advances

173.986

202.477

142.971

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

1548.385

1385.425

738.588

 

 

 

 

TOTAL

2493.318

1650.522

901.619

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Total Operational Revenue

5572.211

4488.124

3055.896

 

 

Other Income

NA

NA

NA

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX 

NA

NA

662.587

 

 

 

 

 

Less

TAX                                                                 

NA

NA

171.280

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

661.203

687.910

491.307

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

4808.75

5002.98

3573.14

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Return on Total Assets

(PBT/Total Assets}

(%)

NA

NA

78.42

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

NA

NA

0.96

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.00

0.00

0.05

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

3.52

5.03

3.95

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

1.375

1.375

1.375

Reserves & Surplus

685.558

1373.468

2034.671

Net worth

686.933

1374.843

2036.046

 

 

 

 

long-term borrowings

25.809

0.374

0.000

Short term borrowings

7.477

0.000

0.000

Total borrowings

33.286

0.374

0.000

Debt/Equity ratio

0.048

0.000

0.000

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Total Operational Revenue

3055.896

4488.124

5572.211

 

 

46.868

24.155

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Total Operational Revenue

3055.896

4488.124

5572.211

Profit

491.307

687.910

661.203

 

16.08%

15.33%

11.87%

 


 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

CHANGE OF ADDRESS

 

The registered office of the company has been shifted from 21, New York Tower - A, Near Muktidham Temple Thaltej Cross Road, Thaltej, Ahmedabad – 380054, Gujarat, India to the present address but the same has not been effected in the government registry.

 

FINANCIAL HIGHLIGHTS AND STATE OF AFFAIRS:

 

(a) Financial Performance and Operational Review: During the year, the company has continued its growth momentum, and has achieved total operational revenue of Rs.5572.211 million compared to Rs.4488.124 million in the previous year, recording a growth of 24.15%.

 

Company has not transferred any amount to General Reserve in the financial year (Last year Rs.7.000 million). The Board has also reviewed the affairs of the subsidiary company- Eris Therapeutics Private Limited.

 

(b) Capital Expenditures: the Company continues its focus on backward integration and is pleased to report the commissioning of the Manufacturing Facility at Guwahati. It was commissioned in the first half of the financial year 2014-2015.

 

(c) Material Changes and Commitments: There were no material changes and commitments affecting the business of the company during the year.

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10560776

23/03/2015

500,000,000.00

AXIS BANK LIMITED

RAC AHMEDABAD , SHIVALIK ISHAAN , 4TH FLOOR , NE
AR C N VIDHYALAYA , AMBAWADI, AHMEDABAD, GUJARAT -
380006, INDIA

C49754260

 

FIXED ASSETS

 

v  Tangible Assets

·         Land

·         Buildings

·         Furniture and Fixtures

·         Vehicles

·         Motor Vehicles

·         Office Equipment

·         Computer Equipments

·         Books Periodicals

·         Other equipments

 

v  Intangible Assets

·         Brands and Trade Marks

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.63.19

UK Pound

1

Rs.94.94

Euro

1

Rs.67.66

 

 

INFORMATION DETAILS

 

Information Gathered by :

KAM

 

 

Analysis Done by :

SUC

 

 

Report Prepared by :

KVT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILITY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

7

--RESERVES

1~10

6

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

52

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.